Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor

被引：48

作者：

Barluenga, Sofia ^{[1
]}

Wang, Cuihua ^{[1
]}

Fontaine, Jean-Gonzague ^{[1
]}

Aouadi, Kaiss ^{[1
]}

Beebe, Kristin ^{[2
]}

Tsutsumi, Shinji ^{[2
]}

Neckers, Len ^{[2
]}

Winssinger, Nicolas ^{[1
]}

机构：

[1] Univ Strasbourg 1, Inst Sci & Ingn Supramol, F-67000 Strasbourg, France

[2] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2008年 / 47卷 / 23期

关键词：

antitumor agents; bioorganic chemistry; natural products; solid-phase synthesis; synthesis design;

D O I：

10.1002/anie.200800233

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

(Chemical Equation Presented) Make a clean breast of it: The generation of a library of pochonin Dderivatives by a solid-phase approach has led to the discovery of pochoxime (see scheme), a potent inhibitor of the heat-shock protein 90, with over 100-fold improved incellular activity. Pochoxime was found to be effective in breast tumor xenografts, leading to a reduction in the tumor size. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：4432 / 4435

页数：4

共 37 条

[21] Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells
Peng, Cong
Brain, Julia
Hu, Yiguo
Goodrich, Ami
Kong, Linghong
Grayzel, David
Pak, Roger
Read, Margaret
Li, Shaoguang
[J]. BLOOD, 2007, 110 (02) : 678 - 685
[22] Inhibition of Hsp90 with synthesis macrolactones: Synthesis and structural and biological evaluation of ring and conformational analogs of radicicol
Proisy, Nicolas
Sharp, Swee Y.
Boxall, Kathy
Connelly, Stephen
Roe, S. Mark
Prodromou, Chrisostomos
Slawin, Alexandra M. Z.
Pearl, Laurence H.
Workman, Paul
Moody, Christopher J.
[J]. CHEMISTRY & BIOLOGY, 2006, 13 (11): : 1203 - 1215
[23] Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO
[24] 2
[25] Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol
Sharma, SV
Agatsuma, T
Nakano, H
[J]. ONCOGENE, 1998, 16 (20) : 2639 - 2645
[26] Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease
Sittler, A
Lurz, R
Lueder, G
Priller, J
Hayer-Hartl, MK
Hartl, FU
Lehrach, H
Wanker, EE
[J]. HUMAN MOLECULAR GENETICS, 2001, 10 (12) : 1307 - 1315
[27] Soga S, 1999, CANCER RES, V59, P2931
[28] Solit DB, 2003, CANCER RES, V63, P2139
[29] Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90
Sydor, Jens R.
Normant, Emmanuel
Pien, Christine S.
Porter, James R.
Ge, Jie
Grenier, Louis
Pak, Roger H.
Ali, Janid A.
Dembski, Marlene S.
Hudak, Jebecka
Patterson, Jon
Penders, Courtney
Pink, Melissa
Read, Margaret A.
Sang, Jim
Woodward, Caroline
Zhang, Yilong
Grayzel, David S.
Wright, Jim
Barrett, John A.
Palombella, Vito J.
Adams, Julian
Tong, Jeffrey K.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) : 17408 - 17413
[30] Targeting wide-range oncogenic transformation via PU24FCI, a specific inhibitor of tumor Hsp90
Vilenchik, M
Solit, D
Basso, A
Huezo, H
Lucas, B
He, HZ
Rosen, N
Spampinato, C
Modrich, P
Chiosis, G
[J]. CHEMISTRY & BIOLOGY, 2004, 11 (06): : 787 - 797

← 1 2 3 4 →